Category: monotherapy
ROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab)
ROACTEMRA 162 MG INJ SRG 0,9 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 10 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 20 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatmen
View DetailsROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab)
ROACTEMRA 20 MG/ML INJ FL 4 ML (Tocilizumab) - Maladie rare sans désignation orpheline *Treatment
View DetailsVELCADE 1 MG INJ FL (Bortezomib)
VELCADE 1 MG INJ FL (Bortezomib) - Maladie rare sans désignation orpheline * As monotherapy or in
View DetailsVELCADE 3,5 MG INJ FL 1 (Bortezomib)
VELCADE 3,5 MG INJ FL 1 (Bortezomib) - Maladie rare sans désignation orpheline * As monotherapy o
View DetailsMABTHERA 100 MG PERF FL 10 ML (Rituximab)
MABTHERA 100 MG PERF FL 10 ML (Rituximab) - Maladie rare sans désignation orpheline * Non-Hodgkin
View DetailsMABTHERA 500 MG PERF FL 50 ML (Rituximab)
MABTHERA 500 MG PERF FL 50 ML (Rituximab) - Maladie rare sans désignation orpheline * Non-Hodgkin
View DetailsHUMIRA 40 MG INJ FL 0,8 ML + NEC (Adalimumab)
HUMIRA 40 MG INJ FL 0,8 ML + NEC (Adalimumab) - Maladie rare sans désignation orpheline *In combi
View DetailsHUMIRA 40 MG INJ SRG 0,8 ML + T (Adalimumab)
HUMIRA 40 MG INJ SRG 0,8 ML + T (Adalimumab) - Maladie rare sans désignation orpheline *In combin
View DetailsHUMIRA 40 MG INJ STYLO 0,8 ML + T (Adalimumab)
HUMIRA 40 MG INJ STYLO 0,8 ML + T (Adalimumab) - Maladie rare sans désignation orpheline *In comb
View Details